Drug profile · INN
levonordefrin
MEPIVACAINE HYDROCHLORIDE W/ LEVONORDEFRIN
levonordefrin (MEPIVACAINE HYDROCHLORIDE W/ LEVONORDEFRIN) is a adrenergic receptor alpha-2 agonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — levonordefrin
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
levonordefrin (MEPIVACAINE HYDROCHLORIDE W/ LEVONORDEFRIN) is a adrenergic receptor alpha-2 agonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Adrenergic receptor alpha-2 agonist
Primary target: Adrenergic receptor alpha-2
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is levonordefrin?
levonordefrin (MEPIVACAINE HYDROCHLORIDE W/ LEVONORDEFRIN) is a adrenergic receptor alpha-2 agonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for levonordefrin?
MEPIVACAINE HYDROCHLORIDE W/ LEVONORDEFRIN is a marketed brand name for levonordefrin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of levonordefrin?
levonordefrin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.